Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Penicillin-binding proteins (PBPs) are a group of enzymes crucial for bacterial cell wall synthesis. They possess transglycosylase activity, which polymerizes glycan chains, and transpeptidase activity, which cross-links peptide side chains, providing structural integrity to the bacterial cell wall. PBPs are the primary target for β-lactam antibiotics, which inhibit their activity, leading to bacterial lysis. Resistance can arise through mutations or acquisition of alternative PBPs. Some PBPs also act as sensors regulating antibiotic resistance mechanisms.
Inhibition of transglycosylase and transpeptidase activity, leading to disruption of peptidoglycan cross-linking and bacterial cell wall synthesis
5 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Penicillin-Binding Protein Transglycosylase Activity (PBP).